BlobotP.S.A.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Industry
Authorized Representatives
Dominik Tomasz Koziołage 29 – Management Board Member
Krzysztof Józef Krawczykage 43 – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ArdigenS.A. | $12,513,309.89 | ardigen.com | ||
| IntodnaS.A. | $2,286,118.76 | intodna.com | ||
| Dicellasp. z o.o. | $206,073.49 | dicella.com | ||
| Space Tech Gatewaysp. z o.o. | $48,583.75 | spacetechgateway.com | ||
| Advanced Diagnostic Equipmentsp. z o.o. | $43,171.56 | adediabetics.pl | ||
| Micropurasp. z o.o. | $12,556.50 | micropura.eu | ||
| Alsitechsp. z o.o. | $106.21 | alsitech.pl | ||
| 21 Zmysłów Labsp. z o.o. | – | 21zmyslow.pl | ||
| Ryvu TherapeuticsS.A. | – | ryvu.com | ||
| FungaeP.S.A. | – | fungae.com |
FAQ
The main business activity of Blobot focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on January 19, 2026.
The headquarters is located at: ul. Kazimierza Brodzińskiego 17, 33-100 Tarnów.
The management board consists of: Dominik Tomasz Kozioł (Member of the Management Board) and Krzysztof Józef Krawczyk (President of the Management Board).
The share capital of the company is PLN 10 (approx. $3).
Last updated: 2026-04-05